4-Amino-5-iodopyrimidine, 95.0%, 25g

7-Bromo-2-methyl-[1,2,4]triazolo[1,5-a]pyridine, 95.0%, 100mg

2,6-Dioxaspiro[4.5]decan-9-one, 95%, 5g

(1S,4R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol, 98%, 5g

N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine, 95.0%, 250mg

Buflomedil Hydrochloride, >98.0%(HPLC)(T), 500g

Cyclohexane-1,2-diol, 95.0%, 10g

Mesa de 180 x 155 mm con mesa en cruz incorporada de 75 x 55 mm y placa de cristal transparente

n-Cyclobutyl-4-ethylaniline, 98%, 1g

5-ACETYL-2-AMINO-4-METHYLPYRIMIDINE, 97.0%, 5g

4-Bromo-2-chloro-5-methylpyridine, 95.0%, 5g

1-Methyl-1H-benzo[d][1,3]oxazine-2,4-dione, 95.0%, 5g

N-(4-Methylphenyl)Sulfonylacetamide, 97%, 1g